Ms. MacKay served as Senior Vice President, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services from 2020 to 2025. At West Pharmaceuticals, Ms. MacKay led the legal, compliance, data privacy, regulatory, sustainability, enterprise risk, business continuity, real estate and facilities services, and safety functions. Prior to joining West Pharmaceuticals, she served as the Senior Vice President, General Counsel and Corporate Secretary of The Segal Group, a privately held firm specializing in employee benefits and investment consulting, from 2019 to 2020. From 2003 to 2019, Ms. MacKay served in roles of increasing responsibility at Novartis (NYSE: NVS), including Head, U.S. Legal for Novartis Business Services, Deputy Compliance Officer for Novartis Pharmaceuticals Corporation and Lead Counsel for a large business unit. Prior to Novartis, Ms. MacKay practiced securities law at two large public companies and a law firm. Ms. MacKay currently serves as Vice-Chair of the board of the Community Foundation of New Jersey, a non-profit supporting critical needs across New Jersey, and a member of the Compliance, Audit and Risk Committee for BAYADA Home Health Care, a national health care provider. The Board believes that Ms. MacKay s experience as General Counsel and Corporate Secretary of a publicly traded company, coupled with her extensive risk management and regulatory compliance expertise from navigating highly regulated industries, makes her well-qualified to serve as a director.